Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Sales | 15,884 | 19,932 | 15,527 | 4,602 | 2,402 |
| Cost of Goods | 10,149 | 12,840 | 10,626 | 2,880 | 1,924 |
| Gross Profit | 5,735 | 7,091 | 2,402 | 914 | 478 |
| Operating Expenses | 14,996 | 18,358 | 11,834 | 6,625 | 6,055 |
| Operating Income | -9,112 | -10,426 | -6,307 | -4,023 | -4,653 |
| Interest Expense | 279 | 300 | 301 | 306 | 254 |
| Other Income | -337 | 874 | 833 | 275 | 1,007 |
| Pre-tax Income | -9,728 | -9,851 | -5,774 | -4,054 | -3,900 |
| Income Tax | 31 | 26 | -229 | 257 | 8 |
| Net Income Continuous | -9,759 | -9,877 | -5,580 | -4,296 | -3,907 |
| Net Income | $-9,759 | $-9,877 | $-5,545 | $-4,311 | $-3,907 |
| EPS Basic Total Ops | -52.00 | -58.40 | -35.63 | -35.23 | -32.36 |
| EPS Basic Continuous Ops | -51.99 | -57.90 | -34.38 | -34.37 | -32.21 |
| EPS Diluted Total Ops | -52.00 | -58.40 | -33.00 | -32.98 | -32.21 |
| EPS Diluted Continuous Ops | -51.99 | -57.90 | -33.21 | -32.87 | -32.21 |
| EBITDA(a) | $-7,868 | $-9,223 | $-5,217 | $-3,255 | $-3,896 |